Drug Shortage Report for ACT LATANOPROST/TIMOLOL

Last updated on 2021-05-20 History
Report ID 134730
Drug Identification Number 02436256
Brand name ACT LATANOPROST/TIMOLOL
Common or Proper name LATANOPROST-TIMOLOL 0.005%
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LATANOPROST TIMOLOL
Strength(s) 50MCG 5MG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 2.5ml
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-23
Estimated end date 2021-05-31
Actual end date 2021-05-19
Shortage status Resolved
Updated date 2021-05-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-05-20 French Compare
v8 2021-05-20 English Compare
v7 2021-05-06 French Compare
v6 2021-05-06 English Compare
v5 2021-03-11 French Compare
v4 2021-03-11 French Compare
v3 2021-03-11 English Compare
v2 2021-02-25 French Compare
v1 2021-02-25 English Compare

Showing 1 to 9 of 9